| Financial Year |
March 31 2023 |
| Monetary Funds |
414,504,440.88 |
| Held-for-trading Financial Assets |
482,150.82 |
| Notes Receivable |
11,196,316.27 |
| Accounts Receivable |
198,631,146.40 |
| Advances to Suppliers |
70,020,473.56 |
| Other Receivables |
69,312,174.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
66,557,383.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,709,104.52 |
| Total Current Assets |
930,497,505.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,838,940.69 |
| Investment Properties |
68,481,627.66 |
| Fixed Assetes |
2,311,176,167.63 |
| Under-construction Projects |
95,268,397.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,036,689,674.90 |
| R&D expenses |
-- |
| Goodwill |
9,967,063.08 |
| Long-Term Deferred and Prepaid Expenses |
105,088,757.30 |
| Deferred Income Tax Assets |
39,241,725.97 |
| Other Non-Current Assets |
41,001,602.05 |
| Sub-Total of Non-Current Assets |
3,773,502,026.46 |
| Total Assets |
4,703,999,531.61 |
| Short-Term Loans |
1,656,824,014.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
55,557,738.54 |
| Accounts Payable |
237,958,281.21 |
| Accounts Received In Advance |
32,426,033.66 |
| Employee Compensation Payable |
121,108,916.95 |
| Taxes Payable |
47,163,588.39 |
| Interest Payable |
-- |
| Dividend Payable |
842,265.30 |
| Other payables |
1,100,562,187.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,228,439.07 |
| Other Current Liabilities |
1,516,862.53 |
| Sub-Total of Current Liabilities |
3,297,985,458.56 |
| Long-term Loans |
97,754,070.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
82,324,265.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,198,764.24 |
| Deferred Income Tax Liabilities |
48,537,633.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
235,530,900.15 |
| Total Liabilities |
3,533,516,358.71 |
| Paid-In Capital(Or Share Stock) |
284,476,800.00 |
| Capital Surplus |
654,405,273.59 |
| Surplus Reserve |
139,941,687.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-201,644,746.19 |
| Minority Stockholder's Interest |
255,092,193.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
915,390,979.53 |
| Owner's Equity（Stockholder's Equity） |
1,170,483,172.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,703,999,531.61 |
